$基立福(GRFS.US)$April 22, 2024 Grifols achieves positive results from phase 4 study of Fanhdi® (double-inactivated human anti-hemophilic factor) in patients with von Willebrand Disease Download PDF Grifols’ Fanhdi showed it could be effective, safe and well tolerated in the management of bleeding episodes and for the prevention of bleeding during surgeries in patients with von Willebrand Disease (VWD) VWD, which is caused by a deficiency of von Willebrand factor in plasma, is the most common ...
$基立福(GRFS.US)$Grifols (GRF.MC) is set to launch a private offering of 1 billion euros of 7.5% senior secured notes due April 2030 for the redemption of senior unsecured notes due May 2025. The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
$基立福(GRFS.US)$International Medical Industries, Inc. Announces Partnership With Grifols for Enhanced Medication Safety!!! ((((( guess it may take some time to sink in ))))) Hehehe
$基立福(GRFS.US)$Grifols' Nucleic Acid Test for Arbovirus Detection Gets CE Marking MT Newswires· 2 mins ago Grifols (GRF.MC) said Thursday its automated nucleic acid test secured CE marking, representing the first for the medical device. Procleix ArboPlex Assay is designed to screen blood donors to detect arboviruses diseases such as chikungunya, dengue, West Nile, and Zika viruses. The Spanish pharmaceutical group said the test will soon be available worldwide to those accepting the CE...
RECAP Treasury yields jumped on Thursday, and indexes fell after data showed a bigger-than-expected jump in producer prices during February, keeping inflation worries alive. The market reversed from larger declines shortly before closing. With the preliminary closing numbers, the$標普500指數(.SPX.US)$fell 0.29%, the$道瓊斯指數(.DJI.US)$fell 0.35%, the$納斯達克綜合指數(.IXIC.US)$...
Gotham City Research has expressed concerns about Grifols' financial reporting and alleged that the company's debt-to-earnings ratio is likely worse than reported. Gotham has also deemed Grifols' shares as 'uninvestable, and likely worthless', a claim that Grifols has rejected.
$基立福(GRFS.US)$today announced positive topline results from AdFirst phase 3 study confirming the efficacy of fibrinogen concentrate in reducing intraoperative blood loss.
基立福股票討論區
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
Really thought this added news today woulda brought more interest?
Update
MT Newswires· 2 mins ago
Grifols (GRF.MC) said Thursday its automated nucleic acid test secured CE marking, representing the first for the medical device.
Procleix ArboPlex Assay is designed to screen blood donors to detect arboviruses diseases such as chikungunya, dengue, West Nile, and Zika viruses.
The Spanish pharmaceutical group said the test will soon be available worldwide to those accepting the CE...
專欄Wall Street Today | Indexes Retreat as Investors Digest Mon. and Tues. Inflation Data
Treasury yields jumped on Thursday, and indexes fell after data showed a bigger-than-expected jump in producer prices during February, keeping inflation worries alive. The market reversed from larger declines shortly before closing.
With the preliminary closing numbers, the $標普500指數(.SPX.US)$ fell 0.29%, the $道瓊斯指數(.DJI.US)$ fell 0.35%, the $納斯達克綜合指數(.IXIC.US)$...
暫無評論